Addressing the unique challenges of opioid use disorder in women
Published Date:January 17, 2017
Corporate Authors:Centers for Disease Control and Prevention (U.S.). Office of the Associate Director for Communication. ; National Center for Injury Prevention and Control (U.S.). Division of Analysis Research and Practice Integration. ;
Series:Public Health grand rounds ; 2017 January 17
Description:The Opioid Overview Crisis and the Federal Response [PDF version of the PowerPoint presentation by Montrece Karin A. Mack, p. 2-26] -- Comprehensive Approaches to Care of Women with Substance Use Disorders [PDF version of the PowerPoint presentation by Linda Frazier, p. 28-28] -- Prevention of Substance Use through Integration into Healthcare [PDF version of the PowerPoint presentation by Mishka Terplan, p. 49-75].
Tuesday, January 17, 2017 at 1 p.m. EST
Deaths from drug overdoses are the number one cause of injury death in the U.S. Most of these deaths are related to the misuse of prescription opioids and heroin. While men were more likely than women to die of opioid overdose, the number of overdose deaths from opioids among women has increased substantially. Since 1999, women’s deaths have quadrupled from prescription opioid overdose.
Consider the following:
• Nearly 48,000 women died of prescription opioid overdose between 1999 and 2010.
• For every woman who dies of a prescription opioid overdose, over 30 of them go the emergency department for opioid misuse or abuse.
Women’s biological differences may influence susceptibility to substance abuse, which could have implications for prevention and treatment. In order to identify and treat women most at risk, health care providers must be able to recognize and consider these differences.
Join us as we discuss how health care providers, researchers, and the public health community can best address the complexities of opioid use disorder among women. Speakers will give an overview of the federal response to the disorder, along with approaches to care and prevention of substance use.
Presented by: Karin A. Mack, PhD, Associate Director for Science, Division of Analysis Research and Practice Integration, National Center for Injury Prevention and Control, CDC [“Overview of Opioid Use Disorder in Women and the Federal Response”]; Linda Frazier, RN, MCHES, CADC, Director, Addictions Initiatives, Chair, APHA ATOD Section, Advocates for Human Potential, Inc.
[“Comprehensive Approaches to Care of Women with Substance Use Disorders”]; Mishka Terplan, MD, MPH, FACOG, FASAM, Professor, Department of Obstetrics and Gynecology, Professor, Department of Psychiatry, Associate Director, Addiction Medicine, Virginia Commonwealth University [“Prevention of Substance Use through Integration into Healthcare”].
Facilitated by: John Iskander, MD, MPH, Scientific Director, Public Health Grand Rounds; Phoebe Thorpe, MD, MPH, Deputy Scientific Director, Public Health Grand Rounds; Susan Laird, MSN, RN, Communications Director, Public Health Grand Rounds.
Supporting Files:No Additional Files
You May Also Like: